XML 69 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pay vs Performance Disclosure      
Pay vs Performance Disclosure, Table
Pay Versus Performance
As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation
S-K,
we are providing the following disclosure regarding executive compensation for our principal executive officer (“PEO”) and
non-PEO
NEOs and Company performance for the fiscal years listed below. For further information concerning the Company’s variable
pay-for-performance
philosophy and how the Company aligns executive compensation with the Company’s performance, refer to “Compensation Discussion and Analysis” on page [
].
Pay Versus Performance Table
 
Year
 
Summary
Compensation
Table Total for
Michael
Goettler
(PEO)
(1)
   
Compensation
Actually Paid
to Michael
Goettler
(PEO)
(1)(2)(3)
   
Average
Summary
Compensation
Table Total for
non-PEO

NEOs
(1)
   
Average
Compensation
Actually Paid
to
non-PEO

NEOs
(1)(2)(3)
   
Value of
Initial
Fixed $100
Investment
Based on
TSR
(4)
   
Peer
Group
TSR
(5)
   
Net
Income
(6)(7)
   
Free Cash
Flow
(7)(8)
 
 
($)
   
($)
   
($)
   
($)
   
($)
   
($)
   
($ millions)
   
($ millions)
 
(a)
 
(b)
   
(c)
   
(d)
   
(e)
   
(f)
   
(g)
   
(h)
   
(i)
 
2022
    14,771,270       14,343,391       14,937,678       13,714,272       74.84       152.44       2,079       2,547  
2021
    14,779,570       13,637,943       10,468,732       5,996,167       87.32       141.38       (1,269     2,560  
2020
    5,472,905       6,397,981       13,208,230       13,982,122       118.20       113.12       (670     989  
 
(1)
The dollar amounts reported in column (b) are the amounts of total compensation reported for Mr. Goettler (who served as our CEO until April 1, 2023) for each corresponding year in the “Total” column of the Summary Compensation Table. Refer to Summary Compensation Table on page [
]. The dollar amounts reported in column (d) represent the average of the amounts reported for the Company’s NEOs as a group (excluding Mr. Goettler) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the NEOs (excluding Mr. Goettler) included for purposes of calculating the average amounts in each applicable year are Sanjeev Narula, Rajiv Malik, Anthony Mauro and Robert J. Coury.
(2)
The amounts shown for compensation actually paid have been calculated in accordance with Item 402(v) of Regulation
S-K
(“Compensation Actually Paid”) and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.
(3)
In accordance with the requirements of Item 402(v) of Regulation
S-K,
adjustments were made to total compensation for each year to determine the compensation actually paid as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Pension Benefit Adjustments Column are based on the service cost for services rendered during the listed year and any prior service cost related to plan amendments or initiations.
PEO SCT Total to CAP Reconciliation
 
    
Summary
Compensation
Table Total for
Michael
Goettler (PEO)
    
Reported
Change in
Pension Value
for
Michael
Goettler
(PEO)
(a)
    
Reported Value
of Equity Awards
for
Michael Goettler
(PEO)
(b)
   
Pension
Benefit
Adjustments
for Michael
Goettler
(PEO)
(c)
    
Equity Award
Adjustments
for Michael
Goettler
(PEO)
(d)
    
Compensation
Actually Paid to
Michael
Goettler (PEO)
 
Year
  
($)
    
($)
    
($)
   
($)
    
($)
    
($)
 
2022
     14,771,270               (9,100,001            8,672,122        14,343,391  
2021
     14,779,570               (9,100,015            7,958,388        13,637,943  
2020
     5,472,905               (2,400,000            3,325,076        6,397,981  
 
Average non-PEO NEOs SCT Total to CAP Reconciliation
 
 
 
  
Average Summary
Compensation
Table Total for
non-PEO NEOs
    
Average
Reported
Change in
Pension
Value for
non-PEO

NEOs
(a)
   
Average
Reported
Value of
Equity
Awards
for
non-PEO

NEOs
(b)
   
Average
Pension
Benefit
Adjustments
for non-PEO

NEOs
(c)
    
Average
Equity
Award
Adjustments
for non-PEO

NEOs
(d)
    
Average
Compensation
Actually Paid to
non-PEO NEOs
 
Year
  
($)
    
($)
   
($)
   
($)
    
($)
    
($)
 
2022
     14,937,678              (6,150,008            4,926,603        13,714,272  
2021
     10,468,732              (6,000,014            1,527,448        5,996,167  
2020
     13,208,230        (84,073     (5,744,245            6,602,209        13,982,122  
 
(a)
The amounts included in this column are the changes in pension value reported in “Change in Pension Value and Non
-
qualified Deferred Compensation Earnings” column of the Summary Compensation Table on page [•] for each applicable year.
(b)
The amounts included in this column represent the total of the amounts reported in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table on page [
] for each applicable year.
(c)
The total pension benefit adjustments for each applicable year include the aggregate of two components: (i) the actuarially determined service cost for services rendered by each NEO during the applicable year (the “service cost”); and (ii) the entire cost of benefits granted in a plan amendment (or initiation) during the applicable year that are attributed by the benefit formula to services rendered in periods prior to the plan amendment or initiation (the “prior service cost”), in each case, calculated in accordance with U.S. GAAP. There were no such costs for any NEO (including Mr. Goettler) during the covered period.
(d)
The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the
year-end
fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in the fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in the fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:
PEO Equity Component of CAP
 
 
 
 
Year-End Fair

Value of
Equity
Awards
Granted
During Year
That
Remained
Unvested as
of Last Day
of Year for
Michael
Goettler
(PEO)
   
Change in
Fair Value
from Last
Day of Prior
Year to Last
Day of Year
of Unvested
Equity
Awards for
Michael
Goettler
(PEO)
   
Vesting-
Date Fair
Value of
Equity
Awards
Granted
During Year
that Vested
During Year
for Michael
Goettler
(PEO)
   
Change in
Fair Value
from Last
Day of Prior
Year to
Vesting
Date of
Unvested
Equity
Awards
that Vested
During Year
for Michael
Goettler
(PEO)
   
Fair Value
at Last Day
of Prior
Year of
Equity
Awards
Forfeited
During Year
for Michael
Goettler
(PEO)
   
Value of
Dividends
or Other
Earnings
Paid on
Equity
Awards Not
Otherwise
Included for
Michael
Goettler
(PEO)
   
Total Equity
Award
Adjustments
for Michael
Goettler (PEO)
 
Year
 
($)
   
($)
   
($)
   
($)
   
($)
   
($)
   
($)
 
2022
    10,405,453       (1,284,199           (449,132                 8,672,122  
2021
    8,821,950       (849,951           (13,611                 7,958,388  
2020
    3,325,076                                     3,325,076  
 
Average non-PEO NEOs Equity Component of CAP
 
 
 
 
Average
Year-End

Fair Value
of Equity
Awards
Granted
During Year
That
Remained
Unvested as
of Last Day
of Year for
non-PEO

NEOs
   
Average
Change in
Fair Value
from Last
Day of Prior
Year to Last
Day of Year
of Unvested
Equity
Awards for
non-PEO

NEOs
   
Average
Vesting-
Date Fair
Value of
Equity
Awards
Granted
During
Year that
Vested
During
Year for
non-PEO

NEOs
   
Average
Change in
Fair Value
from Last
Day of Prior
Year to
Vesting
Date of
Unvested
Equity
Awards
that Vested
During Year
for non-PEO
NEOs
   
Average
Fair Value
at Last Day
of Prior
Year of
Equity
Awards
Forfeited
During Year
for non-PEO
NEOs
   
Average
Value of
Dividends or
Other
Earnings
Paid on
Equity
Awards Not
Otherwise
Included for
non-PEO
NEOs
   
Total - Average

Equity Award
Adjustments
for non-PEO

NEOs
 
Year
 
($)
   
($)
   
($)
   
($)
   
($)
   
($)
   
($)
 
2022
    7,032,266       (1,679,859           (425,804                 4,926,603  
2021
 
 
5,816,674
 
 
 
(3,675,929
 
 
 
 
 
(613,297
 
 
 
 
 
 
 
 
1,527,448
 
2020
    6,923,584       (213,242           (108,133                 6,602,209  
 
(4)
Cumulative TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period.
(5)
The Peer Group TSR set forth in this table utilizes the Dow Jones U.S. Pharmaceuticals Index, which is also the published industry or
line-of-business
index we utilized in the stock performance graph required by Item 201(e) of Regulation
S-K
included in the Form 10-K. Viatris common stock has been listed on the NASDAQ under the symbol “VTRS” since November 17, 2020. Prior to that time, there was no public market for our common stock. Upon consummation of the Combination, Pfizer stockholders received approximately 0.124079 shares of Viatris common stock for every one share of Pfizer common stock held as of the close of business on the record date (which was November 13, 2020). Former Mylan N.V. (“Mylan”) ordinary shareholders received one share of Viatris common stock for every one share of Mylan ordinary share held. The comparison assumes $100 was invested in Company stock for the period starting November 16, 2020, and in the Dow Jones U.S. Pharmaceuticals Index starting October 31, 2020 (with the reinvestment of all dividends) through the end of the listed year. Historical stock performance is not necessarily indicative of future stock performance.
(6)
The dollar amounts reported represent the amount of net earnings (loss) reflected in the Company’s audited financial statements for the applicable year.
(7)
In accordance with Accounting Standards Codification 805, Business Combinations, Mylan is considered the accounting acquirer of the Upjohn business and all historical financial information of the Company prior to November 16, 2020 represents Mylan’s historical results and the Company’s thereafter.
(8)
We determined Free Cash Flow (as reported) to be the most important financial performance measure used to link Company performance to Compensation Actually Paid to our PEO and
non-PEO
NEOs in 2022. Free Cash Flow (as reported) refers to U.S. GAAP net cash provided by operating activities less capital expenditures. We may determine a different financial performance measure to be the most important financial performance measure in future years.
   
Company Selected Measure Name Free Cash Flow    
Named Executive Officers, Footnote The dollar amounts reported in column (d) represent the average of the amounts reported for the Company’s NEOs as a group (excluding Mr. Goettler) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the NEOs (excluding Mr. Goettler) included for purposes of calculating the average amounts in each applicable year are Sanjeev Narula, Rajiv Malik, Anthony Mauro and Robert J. Coury.    
Peer Group Issuers, Footnote
(5)
The Peer Group TSR set forth in this table utilizes the Dow Jones U.S. Pharmaceuticals Index, which is also the published industry or
line-of-business
index we utilized in the stock performance graph required by Item 201(e) of Regulation
S-K
included in the Form 10-K. Viatris common stock has been listed on the NASDAQ under the symbol “VTRS” since November 17, 2020. Prior to that time, there was no public market for our common stock. Upon consummation of the Combination, Pfizer stockholders received approximately 0.124079 shares of Viatris common stock for every one share of Pfizer common stock held as of the close of business on the record date (which was November 13, 2020). Former Mylan N.V. (“Mylan”) ordinary shareholders received one share of Viatris common stock for every one share of Mylan ordinary share held. The comparison assumes $100 was invested in Company stock for the period starting November 16, 2020, and in the Dow Jones U.S. Pharmaceuticals Index starting October 31, 2020 (with the reinvestment of all dividends) through the end of the listed year. Historical stock performance is not necessarily indicative of future stock performance.
   
PEO Total Compensation Amount $ 14,771,270 $ 14,779,570 $ 5,472,905
PEO Actually Paid Compensation Amount $ 14,343,391 13,637,943 6,397,981
Adjustment To PEO Compensation, Footnote
PEO SCT Total to CAP Reconciliation
 
    
Summary
Compensation
Table Total for
Michael
Goettler (PEO)
    
Reported
Change in
Pension Value
for
Michael
Goettler
(PEO)
(a)
    
Reported Value
of Equity Awards
for
Michael Goettler
(PEO)
(b)
   
Pension
Benefit
Adjustments
for Michael
Goettler
(PEO)
(c)
    
Equity Award
Adjustments
for Michael
Goettler
(PEO)
(d)
    
Compensation
Actually Paid to
Michael
Goettler (PEO)
 
Year
  
($)
    
($)
    
($)
   
($)
    
($)
    
($)
 
2022
     14,771,270               (9,100,001            8,672,122        14,343,391  
2021
     14,779,570               (9,100,015            7,958,388        13,637,943  
2020
     5,472,905               (2,400,000            3,325,076        6,397,981  
(a)
The amounts included in this column are the changes in pension value reported in “Change in Pension Value and Non
-
qualified Deferred Compensation Earnings” column of the Summary Compensation Table on page [•] for each applicable year.
(b)
The amounts included in this column represent the total of the amounts reported in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table on page [
] for each applicable year.
(c)
The total pension benefit adjustments for each applicable year include the aggregate of two components: (i) the actuarially determined service cost for services rendered by each NEO during the applicable year (the “service cost”); and (ii) the entire cost of benefits granted in a plan amendment (or initiation) during the applicable year that are attributed by the benefit formula to services rendered in periods prior to the plan amendment or initiation (the “prior service cost”), in each case, calculated in accordance with U.S. GAAP. There were no such costs for any NEO (including Mr. Goettler) during the covered period.
(d)
The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the
year-end
fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in the fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in the fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:
PEO Equity Component of CAP
 
 
 
 
Year-End Fair

Value of
Equity
Awards
Granted
During Year
That
Remained
Unvested as
of Last Day
of Year for
Michael
Goettler
(PEO)
   
Change in
Fair Value
from Last
Day of Prior
Year to Last
Day of Year
of Unvested
Equity
Awards for
Michael
Goettler
(PEO)
   
Vesting-
Date Fair
Value of
Equity
Awards
Granted
During Year
that Vested
During Year
for Michael
Goettler
(PEO)
   
Change in
Fair Value
from Last
Day of Prior
Year to
Vesting
Date of
Unvested
Equity
Awards
that Vested
During Year
for Michael
Goettler
(PEO)
   
Fair Value
at Last Day
of Prior
Year of
Equity
Awards
Forfeited
During Year
for Michael
Goettler
(PEO)
   
Value of
Dividends
or Other
Earnings
Paid on
Equity
Awards Not
Otherwise
Included for
Michael
Goettler
(PEO)
   
Total Equity
Award
Adjustments
for Michael
Goettler (PEO)
 
Year
 
($)
   
($)
   
($)
   
($)
   
($)
   
($)
   
($)
 
2022
    10,405,453       (1,284,199           (449,132                 8,672,122  
2021
    8,821,950       (849,951           (13,611                 7,958,388  
2020
    3,325,076                                     3,325,076  
   
Non-PEO NEO Average Total Compensation Amount $ 14,937,678 10,468,732 13,208,230
Non-PEO NEO Average Compensation Actually Paid Amount $ 13,714,272 5,996,167 13,982,122
Adjustment to Non-PEO NEO Compensation Footnote
Average non-PEO NEOs SCT Total to CAP Reconciliation
 
 
 
  
Average Summary
Compensation
Table Total for
non-PEO NEOs
    
Average
Reported
Change in
Pension
Value for
non-PEO

NEOs
(a)
   
Average
Reported
Value of
Equity
Awards
for
non-PEO

NEOs
(b)
   
Average
Pension
Benefit
Adjustments
for non-PEO

NEOs
(c)
    
Average
Equity
Award
Adjustments
for non-PEO

NEOs
(d)
    
Average
Compensation
Actually Paid to
non-PEO NEOs
 
Year
  
($)
    
($)
   
($)
   
($)
    
($)
    
($)
 
2022
     14,937,678              (6,150,008            4,926,603        13,714,272  
2021
     10,468,732              (6,000,014            1,527,448        5,996,167  
2020
     13,208,230        (84,073     (5,744,245            6,602,209        13,982,122  
(a)
The amounts included in this column are the changes in pension value reported in “Change in Pension Value and Non
-
qualified Deferred Compensation Earnings” column of the Summary Compensation Table on page [•] for each applicable year.
(b)
The amounts included in this column represent the total of the amounts reported in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table on page [
] for each applicable year.
(c)
The total pension benefit adjustments for each applicable year include the aggregate of two components: (i) the actuarially determined service cost for services rendered by each NEO during the applicable year (the “service cost”); and (ii) the entire cost of benefits granted in a plan amendment (or initiation) during the applicable year that are attributed by the benefit formula to services rendered in periods prior to the plan amendment or initiation (the “prior service cost”), in each case, calculated in accordance with U.S. GAAP. There were no such costs for any NEO (including Mr. Goettler) during the covered period.
(d)
The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the
year-end
fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in the fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in the fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:
Average non-PEO NEOs Equity Component of CAP
 
 
 
 
Average
Year-End

Fair Value
of Equity
Awards
Granted
During Year
That
Remained
Unvested as
of Last Day
of Year for
non-PEO

NEOs
   
Average
Change in
Fair Value
from Last
Day of Prior
Year to Last
Day of Year
of Unvested
Equity
Awards for
non-PEO

NEOs
   
Average
Vesting-
Date Fair
Value of
Equity
Awards
Granted
During
Year that
Vested
During
Year for
non-PEO

NEOs
   
Average
Change in
Fair Value
from Last
Day of Prior
Year to
Vesting
Date of
Unvested
Equity
Awards
that Vested
During Year
for non-PEO
NEOs
   
Average
Fair Value
at Last Day
of Prior
Year of
Equity
Awards
Forfeited
During Year
for non-PEO
NEOs
   
Average
Value of
Dividends or
Other
Earnings
Paid on
Equity
Awards Not
Otherwise
Included for
non-PEO
NEOs
   
Total - Average

Equity Award
Adjustments
for non-PEO

NEOs
 
Year
 
($)
   
($)
   
($)
   
($)
   
($)
   
($)
   
($)
 
2022
    7,032,266       (1,679,859           (425,804                 4,926,603  
2021
 
 
5,816,674
 
 
 
(3,675,929
 
 
 
 
 
(613,297
 
 
 
 
 
 
 
 
1,527,448
 
2020
    6,923,584       (213,242           (108,133                 6,602,209  
   
Compensation Actually Paid vs. Total Shareholder Return
Description of Relationship Between PEO and
non-PEO
NEO Compensation Actually Paid and Company TSR
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our
non-PEO
NEOs, and the Company’s cumulative TSR over the three most recently completed fiscal years.
 
 
LOGO
 
*
$100 invested on November 16, 2020 in Company stock including reinvestment of dividends.
   
Compensation Actually Paid vs. Net Income
Description of Relationship Between PEO and
non-PEO
NEO Compensation Actually Paid and Net Income
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our
non-PEO
NEOs, and our Net Earnings (Loss) during the three most recently completed fiscal years.
 
 
LOGO
 
   
Compensation Actually Paid vs. Company Selected Measure
Description of Relationship Between PEO and
non-PEO
NEO Compensation Actually Paid and Free Cash Flow (as reported)
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our
non-PEO
NEOs, and our Free Cash Flow (as reported) during the three most recently completed fiscal years.
 
 
LOGO
 
   
Total Shareholder Return Vs Peer Group
Description of Relationship Between Company TSR and Peer Group TSR
The following chart compares our cumulative TSR over the three most recently completed fiscal years to that of the Dow Jones US Pharmaceuticals Index over the same period.
 
 
LOGO
   
Tabular List, Table
List of Most Important Financial Performance Me
a
sures
The following presents the financial performance measures that the Company considers to have been the most important in linking Compensation Actually Paid to our PEO and other NEOs for 2022 to Company performance. The measures are not ranked.
 
Most Important Performance Measures
Adjusted EBITDA (as reported)*
Free Cash Flow (as reported)*
Relative TSR
 
*
See Appendix B of this Proxy Statement for reconciliations of 2022 Adjusted EBITDA (as reported) and Free Cash Flow (as reported) to our audited financial statements.
   
Total Shareholder Return Amount $ 74.84 87.32 118.2
Peer Group Total Shareholder Return Amount 152.44 141.38 113.12
Net Income (Loss) $ 2,079,000,000 $ (1,269,000,000) $ (670,000,000)
Company Selected Measure Amount 2,547,000,000 2,560,000,000 989,000,000
PEO Name Mr. Goettler    
Measure:: 1      
Pay vs Performance Disclosure      
Name Adjusted EBITDA    
Measure:: 2      
Pay vs Performance Disclosure      
Name Free Cash Flow    
Measure:: 3      
Pay vs Performance Disclosure      
Name Relative TSR    
PEO | Reported Value of Equity Awards [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount $ (9,100,001) $ (9,100,015) $ (2,400,000)
PEO | Equity Award Adjustments [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 8,672,122 7,958,388 3,325,076
PEO | Year End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 10,405,453 8,821,950 3,325,076
PEO | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (1,284,199) (849,951)  
PEO | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (449,132) (13,611)  
Non-PEO NEO | Reported Change in Pension Value [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount     (84,073)
Non-PEO NEO | Reported Value of Equity Awards [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (6,150,008) (6,000,014) (5,744,245)
Non-PEO NEO | Equity Award Adjustments [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 4,926,603 1,527,448 6,602,209
Non-PEO NEO | Year End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 7,032,266 5,816,674 6,923,584
Non-PEO NEO | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (1,679,859) (3,675,929) (213,242)
Non-PEO NEO | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount $ (425,804) $ (613,297) $ (108,133)